A fluorescence-based screening assay for identification of hepatitis C virus NS3 helicase inhibitors and characterization of their inhibitory mechanism

Atsushi Furuta, Kazi Abdus Salam, Hidenori Tani, Satoshi Tsuneda, Yuji Sekiguchi, Nobuyoshi Akimitsu, Naohiro Noda

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Hepatitis C virus (HCV) can establish a chronic infection in the majority of individuals infected, resulting in liver cirrhosis and hepatocellular carcinoma. Because the current standard treatment for HCV infection has limitations in terms of severe side effects, the emergence of drug resistance, and drug–drug interactions, it is desirable to develop novel antivirals that target viral proteins involved in viral replication. HCV nonstructural protein 3 (NS3) helicase, which unwinds double-stranded nucleic acids to yield single-stranded nucleic acids, is one possible target for new drug development, because it plays an essential role in viral replication. In this chapter, we describe a helicase assay based on fluorescence resonance energy transfer (FRET) that can be used for high-throughput screening of HCV NS3 helicase inhibitors. The assay uses a double-stranded RNA (dsRNA) substrate with a fluorophore-labeled strand hybridized to a quencher-labeled strand and monitors the increase in fluorescence intensity resulting from helicase-catalyzed unwinding of the dsRNA substrate. We further describe radioactive assays to directly visualize RNA strands unwound by helicase and to evaluate the ATPase and RNA-binding activities of NS3, which are linked to helicase activity, for characterization of the inhibitory mechanism.

Original languageEnglish
Pages (from-to)211-228
Number of pages18
JournalMethods in Molecular Biology
Volume1259
DOIs
Publication statusPublished - 2015
Externally publishedYes

Fingerprint

Hepacivirus
Fluorescence
Double-Stranded RNA
Nucleic Acids
Proteins
RNA
Fluorescence Resonance Energy Transfer
Viral Proteins
Virus Diseases
Drug-Related Side Effects and Adverse Reactions
Drug Resistance
Liver Cirrhosis
Antiviral Agents
Adenosine Triphosphatases
Hepatocellular Carcinoma
Infection
Pharmaceutical Preparations

Keywords

  • Fluorescence assay
  • Fluorescence resonance energy transfer (FRET)
  • Hepatitis C virus
  • High-throughput screening assay
  • Inhibitor
  • Inhibitory mechanism
  • NS3 helicase
  • Radioactive assay

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

A fluorescence-based screening assay for identification of hepatitis C virus NS3 helicase inhibitors and characterization of their inhibitory mechanism. / Furuta, Atsushi; Salam, Kazi Abdus; Tani, Hidenori; Tsuneda, Satoshi; Sekiguchi, Yuji; Akimitsu, Nobuyoshi; Noda, Naohiro.

In: Methods in Molecular Biology, Vol. 1259, 2015, p. 211-228.

Research output: Contribution to journalArticle

Furuta, Atsushi ; Salam, Kazi Abdus ; Tani, Hidenori ; Tsuneda, Satoshi ; Sekiguchi, Yuji ; Akimitsu, Nobuyoshi ; Noda, Naohiro. / A fluorescence-based screening assay for identification of hepatitis C virus NS3 helicase inhibitors and characterization of their inhibitory mechanism. In: Methods in Molecular Biology. 2015 ; Vol. 1259. pp. 211-228.
@article{c719f7a808d440a3bd8080afdd6d32cb,
title = "A fluorescence-based screening assay for identification of hepatitis C virus NS3 helicase inhibitors and characterization of their inhibitory mechanism",
abstract = "Hepatitis C virus (HCV) can establish a chronic infection in the majority of individuals infected, resulting in liver cirrhosis and hepatocellular carcinoma. Because the current standard treatment for HCV infection has limitations in terms of severe side effects, the emergence of drug resistance, and drug–drug interactions, it is desirable to develop novel antivirals that target viral proteins involved in viral replication. HCV nonstructural protein 3 (NS3) helicase, which unwinds double-stranded nucleic acids to yield single-stranded nucleic acids, is one possible target for new drug development, because it plays an essential role in viral replication. In this chapter, we describe a helicase assay based on fluorescence resonance energy transfer (FRET) that can be used for high-throughput screening of HCV NS3 helicase inhibitors. The assay uses a double-stranded RNA (dsRNA) substrate with a fluorophore-labeled strand hybridized to a quencher-labeled strand and monitors the increase in fluorescence intensity resulting from helicase-catalyzed unwinding of the dsRNA substrate. We further describe radioactive assays to directly visualize RNA strands unwound by helicase and to evaluate the ATPase and RNA-binding activities of NS3, which are linked to helicase activity, for characterization of the inhibitory mechanism.",
keywords = "Fluorescence assay, Fluorescence resonance energy transfer (FRET), Hepatitis C virus, High-throughput screening assay, Inhibitor, Inhibitory mechanism, NS3 helicase, Radioactive assay",
author = "Atsushi Furuta and Salam, {Kazi Abdus} and Hidenori Tani and Satoshi Tsuneda and Yuji Sekiguchi and Nobuyoshi Akimitsu and Naohiro Noda",
year = "2015",
doi = "10.1007/978-1-4939-2214-7_14",
language = "English",
volume = "1259",
pages = "211--228",
journal = "Methods in molecular biology (Clifton, N.J.)",
issn = "1064-3745",
publisher = "Humana Press",

}

TY - JOUR

T1 - A fluorescence-based screening assay for identification of hepatitis C virus NS3 helicase inhibitors and characterization of their inhibitory mechanism

AU - Furuta, Atsushi

AU - Salam, Kazi Abdus

AU - Tani, Hidenori

AU - Tsuneda, Satoshi

AU - Sekiguchi, Yuji

AU - Akimitsu, Nobuyoshi

AU - Noda, Naohiro

PY - 2015

Y1 - 2015

N2 - Hepatitis C virus (HCV) can establish a chronic infection in the majority of individuals infected, resulting in liver cirrhosis and hepatocellular carcinoma. Because the current standard treatment for HCV infection has limitations in terms of severe side effects, the emergence of drug resistance, and drug–drug interactions, it is desirable to develop novel antivirals that target viral proteins involved in viral replication. HCV nonstructural protein 3 (NS3) helicase, which unwinds double-stranded nucleic acids to yield single-stranded nucleic acids, is one possible target for new drug development, because it plays an essential role in viral replication. In this chapter, we describe a helicase assay based on fluorescence resonance energy transfer (FRET) that can be used for high-throughput screening of HCV NS3 helicase inhibitors. The assay uses a double-stranded RNA (dsRNA) substrate with a fluorophore-labeled strand hybridized to a quencher-labeled strand and monitors the increase in fluorescence intensity resulting from helicase-catalyzed unwinding of the dsRNA substrate. We further describe radioactive assays to directly visualize RNA strands unwound by helicase and to evaluate the ATPase and RNA-binding activities of NS3, which are linked to helicase activity, for characterization of the inhibitory mechanism.

AB - Hepatitis C virus (HCV) can establish a chronic infection in the majority of individuals infected, resulting in liver cirrhosis and hepatocellular carcinoma. Because the current standard treatment for HCV infection has limitations in terms of severe side effects, the emergence of drug resistance, and drug–drug interactions, it is desirable to develop novel antivirals that target viral proteins involved in viral replication. HCV nonstructural protein 3 (NS3) helicase, which unwinds double-stranded nucleic acids to yield single-stranded nucleic acids, is one possible target for new drug development, because it plays an essential role in viral replication. In this chapter, we describe a helicase assay based on fluorescence resonance energy transfer (FRET) that can be used for high-throughput screening of HCV NS3 helicase inhibitors. The assay uses a double-stranded RNA (dsRNA) substrate with a fluorophore-labeled strand hybridized to a quencher-labeled strand and monitors the increase in fluorescence intensity resulting from helicase-catalyzed unwinding of the dsRNA substrate. We further describe radioactive assays to directly visualize RNA strands unwound by helicase and to evaluate the ATPase and RNA-binding activities of NS3, which are linked to helicase activity, for characterization of the inhibitory mechanism.

KW - Fluorescence assay

KW - Fluorescence resonance energy transfer (FRET)

KW - Hepatitis C virus

KW - High-throughput screening assay

KW - Inhibitor

KW - Inhibitory mechanism

KW - NS3 helicase

KW - Radioactive assay

UR - http://www.scopus.com/inward/record.url?scp=84921781241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921781241&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-2214-7_14

DO - 10.1007/978-1-4939-2214-7_14

M3 - Article

VL - 1259

SP - 211

EP - 228

JO - Methods in molecular biology (Clifton, N.J.)

JF - Methods in molecular biology (Clifton, N.J.)

SN - 1064-3745

ER -